AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The US DHHS Food & Drug Administration Center for Devices & Radiological Health (CDRH) is considering developing various regulatory guidance documents in fiscal year 2008:
* Guidance on MDUFMA Reauthorization
--30-Day Notices & 135-Day PMA Supplements
--FDA & Industry Actions on Premarket Approval Applications
--FDA & Industry Actions on Premarket Notification Submissions
--Assay Migration Studies for IVDs
--Clinical Trials Using De-IDed Leftover Samples